[Ser8]-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) CAS NO.215777-46-1

[Ser8]-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) CAS NO.215777-46-1

[Ser8]-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) CAS NO.215777-46-1

[Ser8]-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) CAS NO.215777-46-1

[Ser8]-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) CAS NO.215777-46-1

[Ser8]-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) is a multi-species collection of synthetic GLP-1 analogs featuring a specific serine substitution at position 8. This 30-amino acid peptide (C-terminal amide form) is available across five mammalian species, providing researchers with species-matched tools for studying GLP-1 receptor pharmacology, structure-activity relationships, and metabolic regulation. The Ser8 modification may influence peptide stability, receptor binding kinetics, and resistance to enzymatic degradation compared to native sequences. Manufactured under stringent quality controls with HPLC-verified purity and comprehensive analytical documentation, this product enables comparative studies across species and investigation of GLP-1 analog properties.


TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
[Ser8]-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) 
CAS NO.
215777-46-1
Appearance
White to off-white lyophilized powder
Molecular Formula
C149H226N40O46
Molecular Weight
3313.7 g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, acetic acid (0.1%), PBS (pH 7-8)

Endotoxin< 1.0 EU/mg
Biological Activity
Glucagon-like peptide-1 analogues, with a serine (Ser) substitution at position 8; GLP-1 receptor agonists that promote insulin secretion, inhibit glucagon release, and delay gastric emptying.
Storage Conditions
Store at -20°C or below, protected from light and moisture. After reconstitution, aliquot and store at -20°C
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

[Ser8]-GLP-1 (7-36) amide binds to GLP-1 receptors (GLP-1R) expressed on pancreatic beta cells and other target tissues, activating G-protein coupled signaling pathways. The Ser8 substitution at position 8 (typically alanine or serine in native sequences across species) may modulate receptor interaction, potentially affecting binding affinity, signal transduction efficiency, or metabolic stability. This modification can influence the peptide's resistance to dipeptidyl peptidase-4 (DPP-4) cleavage and other proteases, potentially extending its half-life. The peptide increases intracellular cAMP levels, activates protein kinase A (PKA), and stimulates glucose-dependent insulin secretion while inhibiting glucagon release. The species-specific variants allow investigation of how single amino acid changes affect receptor activation and downstream metabolic effects.


2.PRODUCT INDICATIONS

Structure-Activity Relationship Studies: Investigation of how position 8 modifications affect GLP-1 receptor binding and signaling
Comparative Species Research: Evaluation of species-specific differences in GLP-1 receptor pharmacology and metabolic responses
Metabolic Stability Studies: Assessment of Ser8 substitution effects on peptide half-life and protease resistance
Receptor Pharmacology: Characterization of binding kinetics, affinity, and signal transduction using species-matched ligands
Diabetes Research: Exploration of modified GLP-1 analogs for therapeutic development
Cross-Species Validation: Comparison of peptide activity across human and common laboratory animal species


3.CLINICAL EFFICACY OF PRODUCT

Species Coverage: Available for human, bovine, guinea pig, mouse, and rat, enabling comprehensive cross-species research

High Purity: ≥95% by RP-HPLC with mass spectrometry confirmation of species-specific sequences and Ser8 modification

Sequence Accuracy: Each species variant verified for correct amino acid sequence, including Ser8 substitution and C-terminal amidation

Research Utility: Validated for receptor binding studies, functional assays, and species comparison experiments

Quality Documentation: Certificate of Analysis provided for each batch with purity, mass spec, and species identification

Technical Support: Access to species-specific application guidance and experimental design consultation


    4.DELIVERY & SHIPPING

    We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
    Professional and Secure Packaging
    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
    We can also customize packaging according to customer needs.
    Shipping Methods 
    Main Method: International Air Freight

    We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.